You have 9 free searches left this month | to do more

dasatinib

Dasatinib is a drug used to treat Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Leukemia, and other conditions. Dasatinib is being actively studied in 66 studies and prior, has been studied in 110.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionStephen Spurgeon
National Cancer Institute (NCI)M D Anderson Cancer CenterAbhinav Deol
M.D. Anderson Cancer CenterCity of Hope Comprehensive Cancer CenterPhilip C. Amrein, M.D.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Dasatinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-15
Nov 15, 2021
S
Recruiting
  • Dasatinib
  • +2 more
  • Dasatinib
  • Shenzhen, Guangdong, China
    Xin Du
2021-06-09
Jun 9, 2021
M
Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-05
May 5, 2021
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-07
May 7, 2021
B
Active, not recruiting
  • Multiple Indications Cancer
  • Dasatinib
  • Besancon, France
  • +5 more
2021-12-02
Dec 2, 2021
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Dasatinib
  • Decitabine and Cedazuridine
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-29
Dec 29, 2021
O
Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Dasatinib
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-03-15
Mar 15, 2021
N
Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-12-30
Dec 30, 2021
N
Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Dasatinib
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
2021-12-15
Dec 15, 2021
S
Not yet recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2021-06-18
Jun 18, 2021
U
Completed
  • Pancreatic Cancer Metastatic
  • Gainesville, Florida
    UF Health Cancer Center
2020-12-03
Dec 3, 2020
N
Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Dasatinib
  • Icosapent Ethyl
  • (no location specified)
2022-01-19
Jan 19, 2022
U
Active, not recruiting
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Dasatinib
  • +2 more
  • Chicago, Illinois
  • +1 more
2021-10-18
Oct 18, 2021
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
2021-10-07
Oct 7, 2021
I
Active, not recruiting
  • Acute,Leukemia, Lymphoid
  • Dasatinib
  • +12 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
2021-02-08
Feb 8, 2021
C
Active, not recruiting
  • EGFR Gene Mutation
  • Nonsmall Cell Lung Cancer
  • Washington, District of Columbia
  • +1 more
2022-01-09
Jan 9, 2022
H
Recruiting
  • Chronic Myelogenous Leukemia
  • Dasatinib
  • Amman, Jordan
  • +4 more
2021-09-01
Sep 1, 2021
N
Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Dasatinib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
2020-07-17
Jul 17, 2020
B
Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Dasatinib
  • laboratory biomarker analysis
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2020-12-14
Dec 14, 2020
B
Completed
  • Leukemia
  • Dasatinib
  • Vienna, Austria
  • +12 more
2021-02-24
Feb 24, 2021
M
Completed
  • Solid Tumor
  • Washington, District of Columbia
    Washington Cancer Institute
2020-08-03
Aug 3, 2020
F
Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Dasatinib
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021